Hypertension Drug Market: Regional Revenue Share Dominance During 2018-2025


Posted March 19, 2019 by sandeeps88

Report provide extensive analysis of different segments facilitates to understand various products of the market.
 
Hypertension is a condition where the systolic blood pressure rises over 140 mmHg and diastolic blood pressure over 90 mmHg. The precise cause of hypertension is unknown; however, factors such as smoking, obesity, stress, excess sodium, old age, sleep apnea, certain hormonal conditions, kidney diseases, sedentary lifestyle, poor diet, lack of exercise, and drugs & alcohol contribute to the incidence of hypertension.

According to the Centers of Disease Control and Prevention (CDC), hypertension was the primary reason for death of more than 410,000 Americans in 2014. Hypertension is a long-term disease, and thus requires daily administration of antihypertensive drugs, which is anticipated to drive the hypertension drug market.


Download Sample Copy @ www.alliedmarketresearch.com/request-toc-and-sample/2647

In addition, R&D activities related to hypertension drugs is expected to present new opportunities during the forecast period. However, patent expiry of antihypertensive drugs, such as Benicar and Diovan, may hinder the market growth. Furthermore, stringent government regulations, adverse effects of these drugs, and high cost of healthcare leading to undiagnosed hypertension restrict the market.

Major Key Players:

• Actelion Ltd.
• Novartis AG
• Pfizer Inc.
• Johnson &Johnson Ltd.
• Sanofi SA
• Lupin Limited
• Merck & Co.

The market is segmented on the basis of type and geography. Based on type, the market is divided into diuretics, beta blockers, angiotensin-converting enzyme (ACE) inhibitors, alpha-beta blockers, angiotensin II receptor blockers, aldosterone antagonists, calcium channel blockers, renin inhibitors, alpha blockers, central-acting agents, vasodilators, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits:

• The study provides an in-depth analysis of the global Alprazolam powder market, with current trends and future estimations to elucidate the investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
• The report presents a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of different segments facilitates to understand various products of the market.
• Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

Send Enquiry Us @ www.alliedmarketresearch.com/purchase-enquiry/2647

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Allied Market Research
Phone 18007925285
Business Address 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Country United States
Categories Industry , Medical , Research
Tags hypertension drug market
Last Updated March 19, 2019